Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) — Corporate Action

· NSE 🔴 High Importance Neutral
📢 Key Event
Allotment of 296,320 shares under ESOP 2022
🔄 What Changed
Paid-up capital increased to Rs 13.167094 crore; total shares rose to 65,835,470
💡 Investor Takeaway
Employees gain shares, expanding ownership while preserving existing shareholders' proportional rights.

Jagsonpal Pharmaceuticals announced the allotment of 296,320 equity shares of Rs 2 each under its Employee Stock Option Plan 2022, increasing paid-up capital from Rs 13.10783 crore to Rs 13.167094 crore and total shares from 65,539,150 to 65,835,470, with shares ranking pari passu with existing shares.

📄 View Original Announcement (PDF)

About Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,384.48 Cr P/E: 32.1

View full JAGSNPHARM stock details →

📡 Get AI alerts when JAGSNPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JAGSNPHARM — Free

📊 More JAGSNPHARM filings

See all JAGSNPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when JAGSNPHARM files new disclosures

Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JAGSNPHARM — Free

Free account · 2 AI queries/day